Table 7.
Drugs for the treatment of CD
| Drug | Infliximab |
| Dosage | 5 mg/kg per infusion; usually started at wk 0, 2, and 6 and then repeated every 8 wk if necessary |
| Indications | Chronically active disease, steroid-refractory and steroid-dependency, maintenance, fistulae |
| Important side effects | Nausea, headache, abdominal pain, infections, sepsis; infusions reactions (early or delayed), reactivation of tuberculosis |
| Monitoring | Vital signs around infusion |
| Pregnancy | Unknown |
| Comments | Exclude tuberculosis before infusions, consider concommittant use of imunosuppressants (azathioprine) to reduce antibody formation |